Your browser doesn't support javascript.
loading
Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease.
Ryu, Da-Bin; Lim, Ji-Young; Kim, Tae-Woo; Shin, Seoho; Lee, Sung-Eun; Park, Gyeongsin; Min, Chang-Ki.
Afiliação
  • Ryu DB; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Lim JY; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Kim TW; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Shin S; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Lee SE; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Park G; Department of Pathology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
  • Min CK; Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea. Electronic address: ckmin@catholic.ac.kr.
Exp Hematol ; 98: 36-46.e2, 2021 06.
Article em En | MEDLINE | ID: mdl-33811972

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Janus Quinase 1 / Janus Quinase 2 / Doença Enxerto-Hospedeiro Idioma: En Revista: Exp Hematol Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Janus Quinase 1 / Janus Quinase 2 / Doença Enxerto-Hospedeiro Idioma: En Revista: Exp Hematol Ano de publicação: 2021 Tipo de documento: Article